We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. serves customers who are accelerating life sciences research, solving complex analytica... read more Featured Products: More products

Download Mobile App




Enhanced Cuvette-Free UV-Visible Spectrophotometer Now Available

By LabMedica International staff writers
Posted on 20 Oct 2015
The next generation of cuvette-free UV-visible spectrophotometers is now available for biotech and other life science laboratories.

The Thermo Fisher Scientific (Milford, MA, USA) NanoDrop One is the next generation instrument in the NanoDrop series of microvolume UV-visible spectrophotometers and will replace the NanoDrop2000 and 2000C instruments. More...


NanoDrop spectrophotometers utilize a patented microvolume sample retention system to minimize sample consumption and eliminate the need for cuvettes. A variable, auto-range pathlength feature allows users to measure up to 366 times higher sample concentrations than can be measured in a 10 millimeter cuvette making dilution steps unnecessary. The NanoDrop One does everything that its predecessors can and more, including: on-board instrument control via a touch screen display, a broader dynamic range, expanded connectivity and data management options, and enhanced sample analysis and technical support with Acclaro Sample Intelligence.

Acclaro Sample Intelligence technology enhances user understanding of sample quality while delivering accurate quantitative measurements. There are three parts to Acclaro: (i) data analysis algorithms that provide contaminant identification and corrected concentrations, (ii) an embedded sensor and digital image analysis that monitors the sample column for bubbles to ensure measurement integrity and (iii) sample information alerts and on-demand technical support for guided troubleshooting.

The NanoDrop One instrument boasts Auto-Measure functionality, while advances in communication technology enable results to be shared and archived via Wi-Fi, Ethernet or USB.

“Building on the success of previous NanoDrop instruments, used by thousands of scientists worldwide, we have designed the NanoDrop One instrument to provide simplicity and speed as well as information on sample quality. This allows scientists to accurately quantify and qualify nucleic acid and protein samples, so they can make informed decisions on sample use in downstream applications,” said Dr. Voula Kodoyianni, product manager, molecular spectroscopy at Thermo Fisher Scientific.

Related Links:

Thermo Fisher Scientific 



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.